Quality control is an integral part of the New Jersey State Cancer Registry (NJSCR). We review and evaluate the quality and completeness of our data through routine edit programs, visual review, re-abstracting studies and casefinding audits. We also strive to improve data collection activities through targeted training programs for hospital cancer registrars. The NJSCR is funded by the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) Program (#75N91021D00009), Centers for Disease Control and Prevention’s National Program of Cancer Registries (#NU58DP007117) with additional support from the State of New Jersey and the Rutgers Cancer Institute.  The NJSCR is a member of the North American Association of Central Cancer Registries (NAACCR) and the International Association of Cancer Registries (IACR). The NJSCR has been routinely awarded the highest possible ratings for each of the three national surveillance programs, including the NAACCR Gold Standard from 1995 through the present (excluding 2011), the CDC National Program of Cancer Registries Registry of Excellence Award, and the NCI SEER Program 1st Place Award, meeting 14 of 14 data quality indicators.  These awards are based on completeness of cancer case ascertainment, completeness of specific information on the cancer cases, percent of death certificate only cases, percent of duplicate cases, in addition to passing the data through a stringent edit program.